Recombigen Laboratories Private Limited - Company Profile

It is a healthcare private limited company based in Delhi, Delhi, India, established in 1999.
1999 Delhi, Delhi, India Active
Last Updated:
Access Report
About Recombigen Laboratories Private Limited

Recombigen Laboratories Private Limited, a active private limited company, was established on 07 January 1999 in Delhi, Delhi, India. Engaging in medical consumables & supplies within the manufacturing sector, it holds CIN: U24231DL1999PTC097838. Registered under ROC Roc Delhi I. it is unlisted. It has an authorized capital of ₹1.25 Cr and a paid-up capital of ₹5.11 M.

It upholds a compliant status. Employing 7 professional, Its leadership includes Radhika Beri (Director), Rajesh Beri (Director). Past directors included Radhika Beri, Rishu Beri, Sunil Dutt Sethi. It holds ₹10.35 Cr open charges and ₹1.10 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Prop. No. 98, Phase-Ii Badli Industrial Estate, Delhi, Delhi, 110042.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231DL1999PTC097838

  • Registration Number

    097838

  • Incorporation Date

    07 January 1999

  • Authorized Capital

    ₹1.25 Cr

  • Paid-Up Capital

    ₹5.11 M

  • ROC Code

    Roc Delhi I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.25 Cr
  • Paid Up Capital ₹ 5.11 M
  • Company Age 27 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 10.35 Cr
  • Satisfied Charges ₹ 1.10 Cr
  • Revenue Growth **** 11.94%
  • Profit Growth **** 7.26%
  • Ebitda **** 15.81%
  • Net Worth 33.01%
  • Total Assets **** 22.64%
Company report

Recombigen Laboratories Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Recombigen Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Recombigen Laboratories Private Limited?
Current Directors
Name Designation Appointment Date Status
Radhika Beri Director 20 Apr 2022 Current
Rajesh Beri Director 07 Jan 1999 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 05 Apr 2019 Past
Pramod Abcsdd Director 04 Jun 2025 Past
Pramod Abcsdd Director 10 Jul 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Recombigen Laboratories.

Recombigen Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.94% increase. The company also saw a slight improvement in profitability, with a 7.26% increase in profit. The company's net worth Soared by an impressive increase of 33.01%.

Recombigen Laboratories revenue growth over time
Recombigen Laboratories profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 11.94%
*******
*******
*******
*******
Revenue from Operations
*******
 11.83%
*******
*******
*******
*******
Total Assets
*******
 22.64%
*******
*******
*******
*******
Profit or Loss
*******
 7.26%
*******
*******
*******
*******
Net Worth
*******
 33.01%
*******
*******
*******
*******
EBITDA
*******
 15.81%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Recombigen Laboratories?

Unlock access to Recombigen Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹103,516,992.22

Satisfied Charges

₹11,000,000.00

Charges Breakdown by Lending Institutions
  • Yes Bank Limited : 9.11 Cr
  • Sidbi : 0.81 Cr
  • Axis Bank Limited : 0.26 Cr
  • Others : 0.18 Cr
Latest Charge Details
Date Lender Amount Status
08 Aug 2022 Sidbi ₹8.10 M Open
30 Jan 2021 Others ₹1.75 M Open
21 Jun 2019 Axis Bank Limited ₹1.92 M Open
21 Jun 2019 Axis Bank Limited ₹0.67 M Open
25 Oct 2017 Yes Bank Limited ₹9.11 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Recombigen Laboratories?

Recombigen Laboratories has a workforce of 7 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Recombigen Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Recombigen Laboratories's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Recombigen Laboratories
Recent Activity within the Organization
  • Charges

    A charge with Yes Bank Limited of Rs. 9.11 Cr registered on 25 Oct 2017 with Charge ID 100161772 was modified on 22 Jan 2026. was recorded as a recent event.

  • Annual General Meeting

    Progress on Recombigen Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Recombigen Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I. was completed.

  • Charges

    The activity A charge with Sidbi amounted to Rs. 0.81 Cr with Charge ID 100633406 was registered on 08 Aug 2022. was completed.

  • Director Appointment

    The activity Radhika Beri was appointed as a Director was appointed as a Director on 20 Apr 2022 & has been associated with this company since 4 years 1 month . was completed.

  • Charges

    A charge with Others amounted to Rs. 0.18 Cr with Charge ID 100447845 was registered on 30 Jan 2021. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Recombigen Laboratories Private Limited?

The CIN of Recombigen Laboratories Private Limited is U24231DL1999PTC097838.

Where is Recombigen Laboratories Private Limited headquartered?

Recombigen Laboratories Private Limited is headquartered at Prop. No. 98, Phase-Ii Badli Industrial Estate, Delhi, Delhi, 110042.

When was Recombigen Laboratories Private Limited incorporated?

Recombigen Laboratories Private Limited was incorporated on 07 January 1999.

Who are the current directors of Recombigen Laboratories Private Limited?

The current directors of Recombigen Laboratories Private Limited are

What is the primary industry of Recombigen Laboratories Private Limited?

The primary industry of Recombigen Laboratories Private Limited is Manufacturing.

Is Recombigen Laboratories Private Limited a listed company?

Recombigen Laboratories Private Limited is unlisted.

What is the capital structure of Recombigen Laboratories Private Limited?

The authorized capital of Recombigen Laboratories Private Limited is ₹1.25 Cr, and the paid-up capital is ₹5.11 M.

What is the compliance status of Recombigen Laboratories Private Limited?

The compliance status of Recombigen Laboratories Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available